Crossmark

Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis

Crossref DOI link: https://doi.org/10.1007/s12022-021-09687-w

Published Online: 2021-07-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aysal, Anil https://orcid.org/0000-0003-4428-7210
Agalar, Cihan https://orcid.org/0000-0002-9848-0326
Egeli, Tufan https://orcid.org/0000-0003-1834-8630
Unek, Tarkan https://orcid.org/0000-0002-6235-9903
Oztop, Ilhan https://orcid.org/0000-0002-0425-0651
Obuz, Funda https://orcid.org/0000-0001-5615-8251
Sagol, Ozgul https://orcid.org/0000-0001-9136-5635
License Information

Text and Data Mining valid from 2021-07-20

Version of Record valid from 2021-07-20
More Information

Article History

Accepted: 13 June 2021

First Online: 20 July 2021

Declarations

:

: The study protocol was approved by the institutional ethics committee.

: The authors declare no competing interests.